COMMUNIQUÉS West-GlobeNewswire
-
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
27/03/2024 - 13:30 -
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
27/03/2024 - 13:30 -
UPDATE – Tellbio’s Technology Demonstrates that Analysis of Circulating Tumor Cells Can Predict Survival Among Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Radium-223
27/03/2024 - 13:34 -
SFWJ/MedCana Announces Significant Progress Across Its Operations, Eyes Global Expansion and Enhanced Profitability
27/03/2024 - 13:45 -
Årsregnskab 2023 – Et begivenhedsrigt år for selskabet
27/03/2024 - 13:50 -
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
27/03/2024 - 13:55 -
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
27/03/2024 - 14:00 -
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
27/03/2024 - 14:00 -
VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
27/03/2024 - 14:00 -
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
27/03/2024 - 14:00 -
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference
27/03/2024 - 14:00 -
Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillamine to Treat Long COVID
27/03/2024 - 14:08 -
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
27/03/2024 - 14:12 -
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
27/03/2024 - 14:15 -
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
27/03/2024 - 14:16 -
Tevogen Bio Announces Series A-1 Preferred Stock Investment
27/03/2024 - 14:20 -
Indkaldelse Til Ordinær Generalforsamling Den 18. April 2024 Kl. 15:00
27/03/2024 - 14:20 -
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
27/03/2024 - 14:20 -
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
27/03/2024 - 14:36
Pages